{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:31:31Z","timestamp":1762918291206,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Heart failure (HF) is a chronic disease with growing numbers of patients and a significant compromise in quality of life and high mortality. The main purpose of this study was to evaluate the current practices in managing patients with HF among patients admitted to the hospital and discharged with a primary diagnosis of HF and patients managed in the heart function clinic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study is a retrospective chart review of patients admitted to the hospital and discharged with a primary diagnosis of HF. A total of 448 patient charts were reviewed, of which 173 patients were in the hospital group and 275 patients in the Clinic group. 278 (62.1%) were men, and 170 (37.9%) were women. The Clinic group of patients were significantly received guideline-directed medical therapy (Beta-blockers, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Diuretics, Mineralocorticoid receptor antagonists\u2014p\u2009&lt;\u20090.001). The Clinic group of patients (17.1%) were significantly less re-hospitalized (p\u2009&lt;\u20090.001) compared to the Hospital group (28%) at 180\u00a0days. Physician led multidisciplinary Heart function clinics have better adherence to guideline directed medical therapy and significantly lower rates of re-hospitalization thereby providing cost effective heart failure management with usual care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-022-05938-z","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T13:04:49Z","timestamp":1644498289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Managing patients with heart failure: contemporary real-world experience"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0432-1621","authenticated-orcid":false,"given":"Muhammad","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Ripplinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsah","family":"Chalchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dakshina","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,10]]},"reference":[{"issue":"2","key":"5938_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1573403X11309020006","volume":"9","author":"JE Blair","year":"2013","unstructured":"Blair JE, Huffman M, Shah SJ. Heart failure in North America. Curr Cardiol Rev. 2013;9(2):128\u201346.","journal-title":"Curr Cardiol Rev"},{"issue":"10","key":"5938_CR2","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cjca.2017.05.011","volume":"33","author":"S Gandhi","year":"2017","unstructured":"Gandhi S, Mosleh W, Sharma UC, Demers C, Farkouh ME, Schwalm JD. Multidisciplinary heart failure clinics are associated with lower heart failure hospitalization and mortality: systematic review and meta-analysis. Can J Cardiol. 2017;33(10):1237\u201344.","journal-title":"Can J Cardiol"},{"key":"5938_CR3","unstructured":"Heart disease in Canada. Highlights from the Canadian chronic disease surveillance system. Public Health Agency of Canada. [Online]. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/heart-disease-canada-fact-sheet.html."},{"issue":"6","key":"5938_CR4","doi-asserted-by":"publisher","first-page":"e002606","DOI":"10.1161\/JAHA.115.002606","volume":"5","author":"TM Ruppar","year":"2016","unstructured":"Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta-analysis of controlled trials. J Am Heart Assoc. 2016;5(6):e002606","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"5938_CR5","first-page":"810","volume":"44","author":"FA McAlister","year":"2004","unstructured":"McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44(4):810\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"5938_CR6","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Med. 2009;6(7):e1000097.","journal-title":"PLOS Med"},{"key":"5938_CR7","first-page":"59","volume":"11","author":"M Mirra","year":"2014","unstructured":"Mirra M, Vitulano G, Virtuoso N, Tufano N, D\u2019Auria F, De Angelis S, Giudice R, Lambiase A, Gigantino A, Piscione F. Heart failure in a dedicated outpatient clinic: results after 58 month follow-up. Can it be enough? Transl Med Uni. 2014;11:59\u201362.","journal-title":"Transl Med Uni"},{"issue":"5","key":"5938_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ejheart.2003.11.023","volume":"6","author":"F Atienza","year":"2004","unstructured":"Atienza F, Anguita M, Martinez-Alzamora N, Osca J, Ojeda S, Almenar L, Ridocci F, Valles F, de Velasco JA. Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail. 2004;6(5):643\u201352.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"5938_CR9","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0735-1097(02)02140-X","volume":"40","author":"S Capomolla","year":"2002","unstructured":"Capomolla S, Febo O, Ceresa M, Caporotondi A, Guazzotti G, La Rovere M, Ferrari M, Lenta F, Baldin S, Vaccarini C, et al. Cost\/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care. J Am Coll Cardiol. 2002;40(7):1259\u201366.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5938_CR10","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/hrt.2003.014407","volume":"90","author":"M Mejhert","year":"2004","unstructured":"Mejhert M, Kahan T, Persson H, Edner M. Limited long term effects of a management programme for heart failure. Heart. 2004;90(9):1010\u20135.","journal-title":"Heart"},{"issue":"3","key":"5938_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/01.CIR.87.3.755","volume":"87","author":"P Gaudron","year":"1993","unstructured":"Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation. 1993;87(3):755\u201363.","journal-title":"Circulation"},{"issue":"1\u20132","key":"5938_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00944783","volume":"147","author":"S Goldstein","year":"1995","unstructured":"Goldstein S, Sharov VG, Cook JM, Sabbah HN. Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors. Mol Cell Biochem. 1995;147(1\u20132):51\u20135.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"5938_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12872-019-1214-0","volume":"19","author":"S-M Chen","year":"2019","unstructured":"Chen S-M, Fang Y-N, Wang L-Y, Wu M-K, Wu P-J, Yang T-H, Chen Y-L, Hang C-L. Impact of multidisciplinary treatment strategy on systolic heart failure outcome. BMC Cardiovasc Disord. 2019;19(1):220.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"5938_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2014.02.018","volume":"173","author":"M Senni","year":"2014","unstructured":"Senni M, Gavazzi A, Oliva F, Mortara A, Urso R, Pozzoli M, Metra M, Lucci D, Gonzini L, Cirrincione V et al. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. Int J Cardiol. 2014;173(2):163\u20139.","journal-title":"Int J Cardiol"},{"issue":"2","key":"5938_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsha.2016.07.002","volume":"29","author":"K Salem","year":"2017","unstructured":"Salem K, Fallata D, ElSebaie M, Montasser A, ElGedamy K, ElKhateeb O. Congestive heart failure disease management program: 1-Year population experience from a tertiary center heart failure registry in Saudi Arabia. J Saudi Heart Assoc. 2017;29(2):90\u20135.","journal-title":"J Saudi Heart Assoc"},{"issue":"3","key":"5938_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/eurjhf\/hfq002","volume":"12","author":"VP Harjola","year":"2010","unstructured":"Harjola VP, Follath F, Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Hochadel M, Komajda M, Lopez-Sendon JL, Ponikowski P, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail. 2010;12(3):239\u201348.","journal-title":"Eur J Heart Fail"},{"key":"5938_CR17","doi-asserted-by":"publisher","first-page":"l223","DOI":"10.1136\/bmj.l223","volume":"364","author":"CJ Taylor","year":"2019","unstructured":"Taylor CJ, Ordonez-Mena JM, Roalfe AK, Lay-Flurrie S, Jones NR, Marshall T, Hobbs FDR. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000\u20132017: a population-based cohort study. BMJ. 2019;364:l223.","journal-title":"BMJ"},{"issue":"10","key":"5938_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/ejhf.900","volume":"19","author":"JP Ferreira","year":"2017","unstructured":"Ferreira JP, Rossignol P, Machu JL, Sharma A, Girerd N, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL, et al. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017;19(10):1284\u201393.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"5938_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/xJAHA.111.000018","volume":"1","author":"GC Fonarow","year":"2012","unstructured":"Fonarow GC, Albert NM, Curtis AB, Gheorghiade M, Liu Y, Mehra MR, O\u2019Connor CM, Reynolds D, Walsh MN, Yancy CW. Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of IMPROVE HF. J Am Heart Assoc. 2012;1(1):16\u201326.","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"5938_CR20","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1001\/jama.2012.14795","volume":"308","author":"AF Hernandez","year":"2012","unstructured":"Hernandez AF, Mi X, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Qualls LG, Peterson ED, Fonarow GC, Curtis LH. Associations between aldosterone antagonist therapy and risks of mortality and re-admission among patients with heart failure and reduced ejection fraction. JAMA. 2012;308(20):2097\u2013107.","journal-title":"JAMA"},{"issue":"3","key":"5938_CR21","doi-asserted-by":"publisher","first-page":"e002493","DOI":"10.1161\/JAHA.115.002493","volume":"5","author":"S Dev","year":"2016","unstructured":"Dev S, Hoffman TK, Kavalieratos D, Heidenreich P, Wu WC, Schwenke DC, Tracy SJ. Barriers to adoption of mineralocorticoid receptor antagonists in patients with heart failure: a mixed-methods study. J Am Heart Assoc. 2016;5(3):e002493.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"5938_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00392-015-0939-8","volume":"105","author":"MN Hirt","year":"2016","unstructured":"Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T. General practitioners\u2019 adherence to chronic heart failure guidelines regarding medication: the GP-HF study. Clin Res Cardiol. 2016;105(5):441\u201350.","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"5938_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1517\/14740338.2016.1163335","volume":"15","author":"B Pitt","year":"2016","unstructured":"Pitt B, Rossignol P. The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure. Expert Opin Drug Saf. 2016;15(5):659\u201365.","journal-title":"Expert Opin Drug Saf"},{"key":"5938_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ahj.2017.03.011","volume":"188","author":"D Vukadinovic","year":"2017","unstructured":"Vukadinovic D, Lavall D, Vukadinovic AN, Pitt B, Wagenpfeil S, Bohm M. True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: a meta-analysis. Am Heart J. 2017;188:99\u2013108.","journal-title":"Am Heart J"},{"issue":"1","key":"5938_CR25","doi-asserted-by":"publisher","first-page":"e002946","DOI":"10.1161\/CIRCOUTCOMES.116.002946","volume":"10","author":"LB Cooper","year":"2017","unstructured":"Cooper LB, Hammill BG, Peterson ED, Pitt B, Maciejewski ML, Curtis LH, Hernandez AF. Characterization of mineralocorticoid receptor antagonist therapy initiation in high-risk patients with heart failure. Circ Cardiovasc Qual Outcomes. 2017;10(1):e002946","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-05938-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-022-05938-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-05938-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T13:24:45Z","timestamp":1644499485000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-022-05938-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5938"],"URL":"https:\/\/doi.org\/10.1186\/s13104-022-05938-z","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2022,2,10]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the former Regina Research Ethics Board, Saskatchewan Health Authority, Regina, SK, Canada. Waiver of informed consent was approved by the research ethics board as this study meets criteria a-f of Article 5.5 in the Tri-Council Policy Statement-2 (TCPS).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}